PURA Volume Alert - Accumulation With Very Bullish Candle Stick Analysis and $1 M Contract Announcement – PPS Potential to ...
August 01 2016 - 1:33PM
InvestorsHub NewsWire
New York, NY – August 1,
2016 – InvestorsHub NewsWire -- Wall Street Corner Report
announces that Puration, Inc. (PURA) is experiencing high trading
volume today. The online analysis firm, Stock Technical
Analysis, indicates that current candlestick analysis
rates PURA’s potential as very
bullish.
On Thursday last week, July 28, 2016, PURA subtly
announced signing a $1 million contract. The
Company
released news with a headline about independent test results
certifying PURA’s crystal CBD extract at 88% purity and sliding
into the content of the press release mention of a $1 million
contract that had been recently signed and would be formally
announced this week:
“The Company has recently executed its
first collaboration agreement to produce an infused food and
beverage consumer product anticipated to result in $1 million in
revenue within the first year of product sales. The test
results announced today are instrumental to the collaboration
agreement. Look for a formal announcement next week
introducing the products forthcoming from the collaboration
agreement.”
The Wall Street Corner Report first
learned about PURA in conjunction with its ongoing coverage of
North American Cannabis Holdings, Inc. (USMJ). PURA is
aspinoff
of USMJ with a dividend of PURA stock to USMJ shareholders
pending.
The Wall Street Corner Report
considers PURA comparable to an earlier version
of GW
Pharmaceuticals (GWPH) in
that both are developing commercial applications of cannabis
extracts.
Wall Street Corner Report
anticipates PURA to experience an
‘accumulation phase’ with the shareholder base expanding and
diversifying. As the Company’s news becomes more disseminated
throughout the market, Wall Street Corner Report
anticipates a rapid PPS increase to as high as
$1.00.
GWPH has a market cap of $2B - approximately
33 times revenue. The majority of revenue is non-cash
consideration while the company is still largely in a research
phase. If PURA were to achieve a
valuation at only 15 times its forecasted $3 million revenue, the
PPS would be $0.90.
Learn more about Puration Inc., on the
Company’s website:
http://www.purationinc.com/
Wall Street Corner
Report is the
premier discovery site for promising, yet undiscovered small and
micro-cap stocks featuring opportunities in an ethical,
professional, and responsible manner. We're not fiendishly 'short'
sighted nor are we here to dream the impossibly 'long' dream.
We take a practical view on the big ideas of well-intentioned
management and look to profit on each reasonably achievable step
the well intentioned mangers take toward their big
ideas.
http://www.wallstreetcornerreport.com/
https://twitter.com/WallStCornerRpt
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of factors.
Jack Taylor
info@wallstreetcornerreport.com
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Apr 2023 to Apr 2024